Literature DB >> 32071492

Glutathione S-Transferase P1 313 (A > G) Ile105Val Polymorphism Contributes to Cancer Susceptibility in Indian Population: A Meta-analysis of 39 Case-Control Studies.

Raju K Mandal1,2, Rama D Mittal2.   

Abstract

GSTP1 involved in the metabolism of carcinogens and toxins, reduces damage of DNA and act as a suppressor of carcinogenesis. Many studies have reported that 313 A > G polymorphism is associated with different cancer in Indian population, but the results remain conflicting rather than conclusive. Therefore, we have performed meta-analysis to clarify the more precise association of GSPT1 313 A > G polymorphism with cancer risk in Indian population. We retrieved all relevant published literature from PubMed (Medline) and Google scholar web database and included those study only based on the established inclusion criteria. Pooled ORs and 95% CIs were used to appraise the strength of association. Publication bias and sensitivity analysis was also evaluated. A total of 6581 confirmed cancer cases and 8218 controls were included from eligible thirty nine case-controls studies. Pooled analysis suggested that the variant genotypes significantly increased the risk of cancer in allele (G vs. A: OR 1.266, 95% CI 1.129-1.418, p = 0.001), heterozygous (AG vs. AA: OR 1.191, 95% CI 1.047-1.355, p = 0.008), homozygous (GG vs. AA: OR 1.811, 95% CI 1.428-2.297, p = 0.001), dominant (GG + AG vs. AA: OR 1.276, 95% CI 1.110-1.466, p = 0.001) and recessive (GG vs. AG + AA: OR 1.638, 95% CI 1.340-2.002, p = 0.001) genetic models. The stability of these observations was confirmed by a sensitivity analysis. Begger's funnel plot and Egger's test did not reveal any publication bias. This meta-analysis suggests that the GSTP1 313 A > G polymorphism may contribute to genetic susceptibility to cancer in Indian population. However, larger studies and randomized clinical trial will be required to elucidate the biological and molecular mechanism of GSTP1 gene in cancer. © Association of Clinical Biochemists of India 2018.

Entities:  

Keywords:  Cancer; Indian population; Meta-analysis; Metabolic gene; Polymorphism

Year:  2018        PMID: 32071492      PMCID: PMC6995470          DOI: 10.1007/s12291-018-0787-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  61 in total

1.  Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India.

Authors:  R C Sobti; Satinder Kaur; Pushpinder Kaur; Jagmohan Singh; Indu Gupta; Veena Jain; A Nakahara
Journal:  Cancer Genet Cytogenet       Date:  2006-04-15

2.  GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India.

Authors:  Meenu Jain; Shaleen Kumar; Neeraj Rastogi; Punita Lal; Uday C Ghoshal; Anu Tiwari; Mohan C Pant; Mirza Q Baiq; Balraj Mittal
Journal:  Cancer Lett       Date:  2005-12-07       Impact factor: 8.679

3.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

4.  Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.

Authors:  Daya Shankar Lal Srivastava; Dhruva Kumar Mishra; Anil Mandhani; Balraj Mittal; Anant Kumar; Rama Devi Mittal
Journal:  Eur Urol       Date:  2005-03-07       Impact factor: 20.096

5.  Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.

Authors:  Manzoor Ahmad Malik; Rohit Upadhyay; Rama Devi Mittal; Showket Ali Zargar; Balraj Mittal
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 6.  Global Cancer Incidence and Mortality Rates and Trends--An Update.

Authors:  Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-14       Impact factor: 4.254

7.  Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.

Authors:  Volga S Syamala; Leelakumari Sreeja; Vani Syamala; Praveenkumar B Raveendran; Rajan Balakrishnan; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Fam Cancer       Date:  2007-12-14       Impact factor: 2.375

8.  GSTP1 gene Ile105Val polymorphism causes an elevated risk for bladder carcinogenesis in smokers.

Authors:  Arshad Ahmad Pandith; Adil Lateef; Sheikh Shahnawaz; Aashaq Hussain; Tahir Mohiuddin Malla; Niyaz Azad; Fahim Shehjar; Mosin Salim; Zafar Amin Shah
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.

Authors:  Thangarajan Rajkumar; Mani Samson; Ranganathan Rama; Veluswami Sridevi; Urmila Mahji; Rajaraman Swaminathan; Nirmala K Nancy
Journal:  Breast Cancer Res Treat       Date:  2007-12-05       Impact factor: 4.872

10.  Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.

Authors:  Rakhshan Ihsan; Pradeep Singh Chauhan; Ashwani Kumar Mishra; Dhirendra Singh Yadav; Mishi Kaushal; Jagannath Dev Sharma; Eric Zomawia; Yogesh Verma; Sujala Kapur; Sunita Saxena
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

View more
  2 in total

1.  Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.

Authors:  Magdy M Youssef; Afaf M Elsaid; Rasha A El-Saeed; Riyadh T Mukhlif; Hisham Megahed; Adel I Al-Alawy; Rami M Elshazli
Journal:  Biochem Genet       Date:  2021-05-03       Impact factor: 1.890

Review 2.  Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities.

Authors:  Jin-Yu Gong; Si-Yin Peng; Kai Xing; Li Fan; Sheng-Lan Tan; Zhi-Ying Luo; Hai-Yan Yuan; Ping Xu; Jian-Quan Luo
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.